Iterum Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -696 | -342 | -239 | |
EBITDA | -5,650 | -3,948 | -5,422 | -5,360 |
EBIT | -6,001 | -4,297 | -5,683 | -5,368 |
Net Income | -6,509 | -4,891 | -6,582 | -6,094 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,052 | -3,062 | -4,256 | -2,672 |
Cash | 13,026 | 12,652 | 24,125 | 13,406 |
Basic Shares | 39,935 | 34,060 | 19,699 | 20,044 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -254 | -1,750 | -1,800 | -2,104 |
EBITDA | -18,696 | -34,580 | -39,972 | -83,202 |
EBIT | -18,980 | -36,330 | -41,772 | -85,306 |
Net Income | -24,774 | -38,371 | -44,434 | -91,564 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,772 | -39,343 | -18,535 | -15,903 |
Cash | 24,125 | 6,071 | 21,092 | 27,446 |
Basic Shares | 19,699 | 12,962 | 12,237 | 10,891 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.16 |
2025-03-31 | -$0.14 |
2024-12-31 | -$0.12 |
